In 1946 the National Multiple Sclerosis Society was founded, and in 1947 the Society sponsored its first three research projects. Today our investment in innovative research exceeds $974 million, and with this investment we’ve:
- Recruited more than 900 new MS researchers to the field
- Provided early career support and funding to nearly every thought leader in MS research
- Set standards in diagnosis, symptom management, pediatric MS, complementary and alternative medicine, rehabilitation research, clinical trial strategies and stem cell research
- Established the MS field of nerve and myelin repair which resulted in trials for treatment
- Drove research uncovering genes contributing to MS susceptibility and new treatment avenues
- Paved the way for all existing therapies – none of which existed 20 years ago
Learn more about research progress
Read about past research successes
MS research is a high priority for the Society, and we strategically invest in research worldwide to drive solutions for every single person with MS.
Because MS is a complex disease that is different for every individual, we take a comprehensive and focused approach that can propel knowledge, better treatments, health care policies, and new disease management therapies forward, faster. We drive research and collaborate worldwide to stop MS in its tracks, restore lost function, and end the disease forever – for every single person with MS.
We pursue all promising paths, while focusing on priority areas including progressive MS, nervous system repair, gene/environmental risk factors and wellness and lifestyle. And while we drive our priority areas, we remain nimble to seize promising new opportunities.
Read more about how our research programs are driving solutions.